2-bromopalmitate has been researched along with Bone Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, J; He, QJ; Huang, C; Qi, XT; Shao, XJ; Wang, C; Xu, T; Yang, B; Yang, XC; Ying, MD; Zhang, N; Zhu, H | 1 |
1 other study(ies) available for 2-bromopalmitate and Bone Neoplasms
| Article | Year |
|---|---|
2-Bromopalmitate sensitizes osteosarcoma cells to adriamycin-induced apoptosis via the modulation of CHOP.
Topics: Adolescent; Adult; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Child; Doxorubicin; Drug Synergism; Female; Humans; Osteosarcoma; Palmitates; Reactive Oxygen Species; Transcription Factor CHOP; Young Adult | 2019 |